A Low-fat Spread with Added Plant Sterols and Fish Omega-3 Fatty Acids Lowers Serum Triglyceride and LDL-cholesterol Concentrations in Individuals with Modest Hypercholesterolaemia and Hypertriglyceridaemia
Overview
Authors
Affiliations
Purpose: The primary and secondary objectives were to investigate the triglyceride (TG) and LDL-cholesterol (LDL-C) lowering effects of a spread with added plant sterols (PS) and fish oil as compared to a placebo spread.
Methods: This study had a randomized, double-blind, placebo-controlled, parallel group design with two intervention arms. Following a 2-week placebo run-in period, 260 healthy individuals with modestly elevated blood TG (≥ 1.4 mmol/L) and LDL-C (≥ 3.4 mmol/L) concentrations consumed either the placebo or intervention spread for 4 weeks. The intervention spread contained 2.0 g/day PS and 1.0 g/day eicosapentaenoic acid (EPA) + docosahexanoic acid (DHA) from fish oil. Fasting serum lipids and apolipoproteins (Apo) (exploratory) were measured at the end of the run-in and intervention phases.
Results: Four-week consumption of the intervention spread resulted in significantly lower TG (- 10.6%, 95% CI - 16.0 to - 4.9%; P < 0.001) and LDL-C concentrations (- 5.2%; 95% CI - 7.8 to - 2.4%) as compared to placebo. Total cholesterol (- 3.9%; 95% CI - 6.1 to - 1.5%), non-HDL-C (- 5.4%; 95% CI - 8.1 to - 2.7%), remnant-cholesterol (- 8.1%; 95% CI - 3.4 to - 12.5%), ApoAII (- 2.9%; 95% CI - 5.5 to - 0.2%), ApoCIII (- 7.7%; 95% CI - 12.1 to - 3.1%) and ApoB (- 3.2%; 95% CI - 5.9 to - 0.4%) concentrations were also significantly lower, as compared to placebo. No significant treatment effects were found for HDL-cholesterol, ApoAI, ApoCII, Apo E or ApoB/ApoAI.
Conclusions: Four-week consumption of the intervention spread led to significant and clinically relevant decreases in serum TG, LDL-C and other blood lipid concentrations. The study was registered at clinicaltrials.gov (NCT02728583).
Qiu Z, Huang E, Li Y, Du J, Kan J BMC Womens Health. 2024; 24(1):652.
PMID: 39709418 PMC: 11662844. DOI: 10.1186/s12905-024-03488-z.
Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition.
Pokushalov E, Ponomarenko A, Shrainer E, Kudlay D, Miller R Nutrients. 2024; 16(23).
PMID: 39683427 PMC: 11643751. DOI: 10.3390/nu16234033.
A scoping review on natural cholesterol lowering supplements sold in South African pharmacies.
Lee H, Khan R, Vally M, Orchard A Health SA. 2024; 29:2299.
PMID: 38445038 PMC: 10913186. DOI: 10.4102/hsag.v29i0.2299.
Shi L, Zhang D, Ju J, Wang A, Du T, Chen X Front Endocrinol (Lausanne). 2023; 14:1260764.
PMID: 37842298 PMC: 10570462. DOI: 10.3389/fendo.2023.1260764.
Wauquier F, Boutin-Wittrant L, Krisa S, Valls J, Langhi C, Otero Y Nutrients. 2023; 15(8).
PMID: 37111121 PMC: 10145174. DOI: 10.3390/nu15081903.